Montbonnot, France

Hugues Lortat-Jacob

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Saint Ismier, FR (2009 - 2016)
  • Montbonnot, FR (2015 - 2018)

Company Filing History:


Years Active: 2009-2018

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Hugues Lortat-Jacob: Innovator in Antiviral Treatments

Introduction

Hugues Lortat-Jacob is a notable inventor based in Montbonnot, France. He has made significant contributions to the field of antiviral treatments, particularly in the fight against AIDS. With a total of 5 patents, his work focuses on innovative conjugated molecules that can potentially revolutionize treatment options.

Latest Patents

Lortat-Jacob's latest patents include groundbreaking inventions such as "Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to an anionic polypeptide for the treatment of AIDS." This invention relates to a conjugated molecule that includes a peptide derived from the CD4 receptor, linked to an organic molecule that comprises a 5 to 21 amino acid anionic polypeptide. This conjugated molecule is designed for use in antiviral treatment, specifically targeting AIDS. Another significant patent is "Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanion for the treatment of AIDS." Similar to the previous invention, this patent also focuses on a conjugated molecule that can be utilized in antiviral treatments.

Career Highlights

Throughout his career, Lortat-Jacob has worked with prestigious institutions such as the Centre National de la Recherche Scientifique and Institut Pasteur. His research has been pivotal in advancing the understanding and treatment of viral infections.

Collaborations

Lortat-Jacob has collaborated with esteemed colleagues, including David Bonnaffe and Françoise Baleux. These partnerships have contributed to the success of his research and innovations.

Conclusion

Hugues Lortat-Jacob's work in developing conjugated molecules for antiviral treatments showcases his dedication to improving healthcare solutions. His innovative patents and collaborations highlight his significant impact in the field of medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…